Endoscopic Ultrasound Market Size

Endoscopic Ultrasound Market size was valued at USD 1.2 billion in 2023 and is anticipated to witness a CAGR of 6.9% from 2024 to 2032. The endoscopic ultrasound (EUS) market is experiencing growth driven by the rising incidence of gastrointestinal diseases, favorable reimbursement policies, and increasing demand for minimally invasive procedures.

Gastrointestinal diseases, which include conditions such as colorectal cancer, pancreatitis, inflammatory bowel disease (IBD), and gastrointestinal bleeding, are becoming increasingly prevalent worldwide. For instance, according to an article published by The Lancet in 2024, conservative estimates predict more than 10 million new IBD cases in regions such as Asia, South America, Eastern Europe, and Africa by 2050. The incidence of IBD is rapidly accelerating in these areas. This surge in cases is driven by factors such as aging populations, changes in dietary habits, and lifestyle-related risk factors, leading to greater demand for advanced gastrointestinal diagnostics.

Additionally, favorable reimbursement policies for EUS procedures in many regions support market growth by making these advanced diagnostic and therapeutic options more affordable for patients. The economic burden of untreated or late-diagnosed gastrointestinal diseases, which can lead to higher healthcare costs and lower quality of life, highlights the value of investing in early and accurate diagnostic tools like EUS.

Endoscopic ultrasound is a medical procedure that combines endoscopy and ultrasound to obtain detailed images and information about the digestive tract and surrounding tissues and organs. This procedure provides high-resolution images that aid in the accurate diagnosis and management of various gastrointestinal conditions.